Bulgaria vs Ethiopia: Average cost of multi drug-resistant tuberculosis treatment
Bulgaria
6,271 constant 2022 US$
in 2024
Ethiopia
5,583 constant 2022 US$
in 2024
Bulgaria rank
6th
Ethiopia rank
7th
Average cost of multi drug-resistant tuberculosis treatment over time
- Bulgaria
- Ethiopia
How they compare
Bulgaria currently reports 6,271 constant 2022 US$ against 5,583 constant 2022 US$ in Ethiopia, a difference of 688 constant 2022 US$.
That makes Bulgaria's figure about 1.1 times Ethiopia's.
The two have swapped places 3 times across 6 shared years of data; in 2018 it was Ethiopia ahead.
Bulgaria ranks 6th and Ethiopia ranks 7th of 92 countries.
Ethiopia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Ethiopia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,308 constant 2022 US$ | 3,165 constant 2022 US$ | 1,857 constant 2022 US$ | Ethiopia |
| 2020s | 4,840 constant 2022 US$ | 5,661 constant 2022 US$ | 821.2 constant 2022 US$ | Ethiopia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Bulgaria or Ethiopia?
- Bulgaria, at 6,271 constant 2022 US$ against 5,583 constant 2022 US$ in Ethiopia as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Bulgaria and Ethiopia?
- 688 constant 2022 US$, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Ethiopia?
- 6 years are reported by both, from 2018 to 2024.
- How do Bulgaria and Ethiopia rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Bulgaria ranks 6th and Ethiopia ranks 7th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.